US Patent Issued to Institut Gustave Roussy, Institut National de la Sante et de la Recherche Medicale, Universite Paris-Saclay on April 21 for "Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments" (French Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,412, issued on April 21, was assigned to Institut Gustave Roussy (Villejuif, France), Institut National de la Sante et de la Recherche Medicale (Paris) and Universite Paris-Saclay (Gif-sur-Yvette, France).

"Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments" was invented by Laurence Zitvogel (Paris) and Lisa Derosa (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention pertains to the use of bacteria selected amongst Alistipes senegalensis, Dorea longicatena and Eubacterium siraeum for inducin...